<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2340-9894</journal-id>
<journal-title><![CDATA[Ars Pharmaceutica (Internet)]]></journal-title>
<abbrev-journal-title><![CDATA[Ars Pharm]]></abbrev-journal-title>
<issn>2340-9894</issn>
<publisher>
<publisher-name><![CDATA[Universidad de Granada]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2340-98942025000100016</article-id>
<article-id pub-id-type="doi">10.30827/ars.v66i1.31316</article-id>
<title-group>
<article-title xml:lang="en"><![CDATA[Exploration of Knowledge, Attitude, and Practice of Pharmacovigilance Among HealthCare Professionals: A Cross-Sectional Study]]></article-title>
<article-title xml:lang="es"><![CDATA[Exploración del conocimiento, la actitud y la práctica de la farmacovigilancia entre profesionales de la salud: un estudio transversal]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Tripathi]]></surname>
<given-names><![CDATA[Rashmi]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Sachdeva]]></surname>
<given-names><![CDATA[Monika]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Mehta]]></surname>
<given-names><![CDATA[Geetika]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Raj Kumar Goel Institute of Technology (Pharmacy) Department of Pharmacology ]]></institution>
<addr-line><![CDATA[Ghaziabad Uttar Pradesh]]></addr-line>
<country>India</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>03</month>
<year>2025</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>03</month>
<year>2025</year>
</pub-date>
<volume>66</volume>
<numero>1</numero>
<fpage>16</fpage>
<lpage>24</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_arttext&amp;pid=S2340-98942025000100016&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_abstract&amp;pid=S2340-98942025000100016&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_pdf&amp;pid=S2340-98942025000100016&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract  Introduction:  To ensure the safe use of pharmaceuticals and the detection of adverse drug reactions, it is essential to have an understanding of pharmacovigilance. Although India is running the Pharmacovigilance Program of India, still the spontaneous reporting rate is very low. There is a requirement to be aware healthcare professionals about the importance of pharmacovigilance. This study is conducted to assess the knowledge, attitude, and practice of pharmacovigilance among healthcare professionals in the Northern region of Uttar Pradesh.  Material and Methods:  A cross-sectional study was conceptualized by a Google forms-based questionnaire with 16 questions (08 of knowledge, 05 of attitude, and 03 of practice) a suitable means of assessing the essential knowledge, attitude, and practice of pharmacovigilance. The questionnaire was distributed among the healthcare professionals from March 2024 to April 2024.  Result:  390 pretested questionnaires were circulated among healthcare professionals, and 332 of them were answered by the respondents i.e., the response rate was 85.12 %. Among all the respondents 63.25 % were males and 36.74 % were females. It was observed in this study that healthcare professionals have limited theoretical knowledge about pharmacovigilance. Despite a positive attitude toward the requirement of reporting adverse drug reactions, healthcare professionals showed less reporting practice.  Conclusion:  Healthcare professionals lack adequate knowledge and skill in reporting adverse drug reactions but have a positive attitude toward pharmacovigilance programs. Incorporation of adverse drug reaction reporting concepts in education curriculum, training, and voluntary participation of healthcare professionals in adverse drug reaction reporting is very crucial in achieving safety goals and safeguarding public health.]]></p></abstract>
<abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen  Introducción:  Para garantizar el uso seguro de los productos farmacéuticos y la detección de reacciones adversas a los medicamentos, es fundamental tener conocimientos de farmacovigilancia. Aunque la India ejecuta el Programa de Farmacovigilancia de la India, la tasa de notificación espontánea sigue siendo muy baja. Es necesario concienciar a los profesionales sanitarios sobre la importancia de la farmacovigilancia. Este estudio se realiza para evaluar el conocimiento, la actitud y la práctica de la farmacovigilancia entre los profesionales de la salud en la región norte de Uttar Pradesh.  Material y Métodos:  Se conceptualizó un estudio transversal mediante un cuestionario basado en formularios de Google con 16 preguntas (08 de conocimiento, 05 de actitud y 03 de práctica), un medio adecuado para evaluar los conocimientos, actitudes y prácticas esenciales de la farmacovigilancia. . El cuestionario se distribuyó entre los profesionales sanitarios desde marzo de 2024 hasta abril de 2024.  Resultado:  Se circularon 390 cuestionarios pretestados entre los profesionales de la salud, de los cuales 332 fueron respondidos por los encuestados, es decir, la tasa de respuesta fue del 85,12 %. Entre todos los encuestados, el 63,25 % eran hombres y el 36,74 % eran mujeres. Se observó en este estudio que los profesionales de la salud tienen conocimientos teóricos limitados sobre farmacovigilancia. A pesar de una actitud positiva hacia el requisito de informar las reacciones adversas a los medicamentos, los profesionales de la salud mostraron menos práctica de notificación.  Conclusión:  los profesionales de la salud carecen de conocimientos y habilidades adecuados en la notificación de reacciones adversas a medicamentos, pero tienen una actitud positiva hacia los programas de farmacovigilancia. La incorporación de conceptos de notificación de reacciones adversas a medicamentos en el plan de estudios educativo, la capacitación y la participación voluntaria de los profesionales de la salud en la notificación de reacciones adversas a medicamentos es muy crucial para lograr los objetivos de seguridad y salvaguardar la salud pública.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Reacciones adversas a medicamentos]]></kwd>
<kwd lng="es"><![CDATA[Farmacovigilancia]]></kwd>
<kwd lng="es"><![CDATA[notificación espontánea]]></kwd>
<kwd lng="en"><![CDATA[Adverse drug reactions]]></kwd>
<kwd lng="en"><![CDATA[Pharmacovigilance]]></kwd>
<kwd lng="en"><![CDATA[spontaneous reporting]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Alshami]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Azm]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The need for pharmacovigilance activities in Yemen]]></article-title>
<source><![CDATA[Glob J Med Res]]></source>
<year>2014</year>
<volume>4</volume>
<page-range>8-14</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Alayed]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Alkhalifah]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Alharbi]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Alwohaibi]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Farooqui]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Adverse drug reaction (ADR) as a cause of hospitalization at a government hospital in Saudi Arabia: a prospective observational study]]></article-title>
<source><![CDATA[Curr Drug Saf]]></source>
<year>2019</year>
<volume>14</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>192-8</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Letourneau]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Wells]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Walop]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Duclos]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Improving global monitoring of vaccine safety: a survey of national centres participating in the WHO Programme for International Drug Monitoring]]></article-title>
<source><![CDATA[Drug Saf]]></source>
<year>2008</year>
<volume>31</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>389-98</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kalaiselvan]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Srivastava]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Singh]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Gupta]]></surname>
<given-names><![CDATA[SK]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Pharmacovigilance in India: present scenario and future challenges]]></article-title>
<source><![CDATA[Drug Saf]]></source>
<year>2019</year>
<volume>42</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>39-46</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Dutta]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Banerjee]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Basu]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Chaudhry]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Analysis of under-reporting of adverse drug reaction: Scenario in India and neighbouring countries]]></article-title>
<source><![CDATA[IP Int J Compr Adv Pharmacol]]></source>
<year>2020</year>
<volume>5</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>118-24</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<collab>World Health Organization</collab>
<article-title xml:lang=""><![CDATA[Safety of medicines: pharmacovigilance programme of India]]></article-title>
<source><![CDATA[WHO Drug Information]]></source>
<year>2018</year>
<volume>32</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>10-7</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kalaiselvan]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Thota]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Singh]]></surname>
<given-names><![CDATA[GN]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Pharmacovigilance Programme of India: Recent developments and future perspectives]]></article-title>
<source><![CDATA[Indian Journal of Pharmacology]]></source>
<year>2016</year>
<volume>48</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>624-8</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mittal]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Mittal]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Gupta]]></surname>
<given-names><![CDATA[MC]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[An overview of the pharmacovigilance system in India]]></article-title>
<source><![CDATA[Clin Res Regul Aff]]></source>
<year>2016</year>
<volume>33</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>4-8</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kishore]]></surname>
<given-names><![CDATA[TS]]></given-names>
</name>
<name>
<surname><![CDATA[Aswani]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Nikhitha]]></surname>
<given-names><![CDATA[SS]]></given-names>
</name>
<name>
<surname><![CDATA[Bonthagarala]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Sindhu]]></surname>
<given-names><![CDATA[YR]]></given-names>
</name>
<name>
<surname><![CDATA[Ramakrishna]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Nagabhushanam]]></surname>
<given-names><![CDATA[MV]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Current scenario of pharmacovigilance in India and its comparision with USA and EU]]></article-title>
<source><![CDATA[World J Pharmaceut Res]]></source>
<year>2021</year>
<volume>10</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>826-37</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[García-Abeijon]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Costa]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Taracido]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Herdeiro]]></surname>
<given-names><![CDATA[MT]]></given-names>
</name>
<name>
<surname><![CDATA[Torre]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Figueiras]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Factors associated with underreporting of adverse drug reactions by health care professionals: a systematic review update]]></article-title>
<source><![CDATA[Drug Saf]]></source>
<year>2023</year>
<volume>46</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>625-36</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Korde]]></surname>
<given-names><![CDATA[RA]]></given-names>
</name>
<name>
<surname><![CDATA[Radhika]]></surname>
<given-names><![CDATA[MS]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A KAP study of pharmacovigilance among junior residents and interns of a tertiary care hospital]]></article-title>
<source><![CDATA[Int J Basic Clin Pharmacol]]></source>
<year>2018</year>
<volume>7</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>2178-83</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Marko]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A study of knowledge, attitude, and practice of pharmacovigilance among medical students at a tertiary care teaching hospital in Madhya Pradesh, India]]></article-title>
<source><![CDATA[Natl J Physiol Pharm Pharmacol]]></source>
<year>2019</year>
<volume>9</volume>
<numero>9</numero>
<issue>9</issue>
<page-range>851-5</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bepari]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Niazi]]></surname>
<given-names><![CDATA[SK]]></given-names>
</name>
<name>
<surname><![CDATA[Rahman]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Dervesh]]></surname>
<given-names><![CDATA[AM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The comparative evaluation of knowledge, attitude, and practice of different health-care professionals about the pharmacovigilance system of India]]></article-title>
<source><![CDATA[J Adv Pharm Technol Res]]></source>
<year>2019</year>
<volume>10</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>68-74</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Upadhyaya]]></surname>
<given-names><![CDATA[HB]]></given-names>
</name>
<name>
<surname><![CDATA[Vora]]></surname>
<given-names><![CDATA[MB]]></given-names>
</name>
<name>
<surname><![CDATA[Nagar]]></surname>
<given-names><![CDATA[JG]]></given-names>
</name>
<name>
<surname><![CDATA[Patel]]></surname>
<given-names><![CDATA[PB]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Knowledge, attitude and practices toward pharmacovigilance and adverse drug reactions in postgraduate students of Tertiary Care Hospital in Gujarat]]></article-title>
<source><![CDATA[J Adv Pharm Technol Res]]></source>
<year>2015</year>
<volume>6</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>29-34</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Anuradha]]></surname>
<given-names><![CDATA[CR]]></given-names>
</name>
<name>
<surname><![CDATA[Komathi]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Subashree]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A cross-sectional study on the knowledge, attitude, and practices of pharmacovigilance among health-care professionals at a tertiary care teaching hospital]]></article-title>
<source><![CDATA[Natl J Physiol Pharm Pharmacol]]></source>
<year>2020</year>
<volume>10</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>682-7</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mohapatra]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Althab Begum]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Srikanth]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Rani]]></surname>
<given-names><![CDATA[RJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Knowledge, attitude and the practice (KAP) of pharmacovigilance among health care professionals of a tertiary care teaching hospital of South India]]></article-title>
<source><![CDATA[Asian J Pharm Pharmacol]]></source>
<year>2019</year>
<volume>5</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>669-72</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[AlShammari]]></surname>
<given-names><![CDATA[TM]]></given-names>
</name>
<name>
<surname><![CDATA[Almoslem]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Knowledge, attitudes &amp; practices of healthcare professionals in hospitals towards the reporting of adverse drug reactions in Saudi Arabia: a multi-centre cross sectional study]]></article-title>
<source><![CDATA[Saudi Pharm J]]></source>
<year>2018</year>
<volume>26</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>925-31</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Srinivasan]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Sheela]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Mridula]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Knowledge, attitude and practice of pharmacovigilance among the healthcare professionals in a tertiary care hospital &#8211; a questionnaire study]]></article-title>
<source><![CDATA[Biomedical &amp; Pharmacology Journal]]></source>
<year>2017</year>
<volume>10</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>1441-7</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Behera]]></surname>
<given-names><![CDATA[MR]]></given-names>
</name>
<name>
<surname><![CDATA[Tripathy]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Srivastava]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Das]]></surname>
<given-names><![CDATA[MC]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Knowledge, attitude and practice (KAP) of pharmacovigilance among paediatricians of Odisha and factors related to poor reporting of adverse drug reactions]]></article-title>
<source><![CDATA[J Family Med Prim Care]]></source>
<year>2022</year>
<volume>11</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>3524-7</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Khan]]></surname>
<given-names><![CDATA[Z]]></given-names>
</name>
<name>
<surname><![CDATA[Karatas]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Martins]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Jamshed]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Rahman]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Knowledge, attitude, practice and barriers towards pharmacovigilance and adverse drug reactions reporting among healthcare professionals in Turkey: a systematic review]]></article-title>
<source><![CDATA[Curr Med Res Opin]]></source>
<year>2022</year>
<volume>38</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>145-54</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Melo]]></surname>
<given-names><![CDATA[JR]]></given-names>
</name>
<name>
<surname><![CDATA[Duarte]]></surname>
<given-names><![CDATA[EC]]></given-names>
</name>
<name>
<surname><![CDATA[de Araújo Ferreira]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Gonçalves]]></surname>
<given-names><![CDATA[YS]]></given-names>
</name>
<name>
<surname><![CDATA[de Moraes]]></surname>
<given-names><![CDATA[MV]]></given-names>
</name>
<name>
<surname><![CDATA[Arrais]]></surname>
<given-names><![CDATA[PS]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Assessment of knowledge, attitude, and practice of pharmacovigilance among healthcare professionals in Brazil]]></article-title>
<source><![CDATA[J Young Pharm]]></source>
<year>2020</year>
<volume>12</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>255-60</page-range></nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Upadhyaya]]></surname>
<given-names><![CDATA[HB]]></given-names>
</name>
<name>
<surname><![CDATA[Vora]]></surname>
<given-names><![CDATA[MB]]></given-names>
</name>
<name>
<surname><![CDATA[Nagar]]></surname>
<given-names><![CDATA[JG]]></given-names>
</name>
<name>
<surname><![CDATA[Patel]]></surname>
<given-names><![CDATA[PB]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Knowledge, attitude and practices toward pharmacovigilance and adverse drug reactions in postgraduate students of Tertiary Care Hospital in Gujarat]]></article-title>
<source><![CDATA[J Adv Pharm Technol Res]]></source>
<year>2015</year>
<volume>6</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>29-34</page-range></nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Meher]]></surname>
<given-names><![CDATA[BR]]></given-names>
</name>
<name>
<surname><![CDATA[Joshua]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Asha]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Mukherji]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A questionnaire based study to assess knowledge, attitude and practice of pharmacovigilance among undergraduate medical students in a Tertiary Care Teaching Hospital of South India]]></article-title>
<source><![CDATA[Perspect Clin Res]]></source>
<year>2015</year>
<volume>6</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>217-21</page-range></nlm-citation>
</ref>
<ref id="B24">
<label>24</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hayek]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Sridhar]]></surname>
<given-names><![CDATA[SB]]></given-names>
</name>
<name>
<surname><![CDATA[Rabbani]]></surname>
<given-names><![CDATA[SA]]></given-names>
</name>
<name>
<surname><![CDATA[Shareef]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Wadhwa]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Exploring pharmacovigilance practices and knowledge among healthcare professionals: A cross-sectional multicenter study]]></article-title>
<source><![CDATA[SAGE Open Med]]></source>
<year>2024</year>
<volume>12</volume>
<page-range>1-14</page-range></nlm-citation>
</ref>
<ref id="B25">
<label>25</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Balan]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Knowledge, attitude and practice of Malaysian healthcare professionals toward adverse drug reaction reporting: a systematic review]]></article-title>
<source><![CDATA[Int J Pharm Pract]]></source>
<year>2021</year>
<volume>29</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>308-20</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
